Regeneron Pharmaceuticals, Inc
Primary Climate Goal
This company has not set a company-wide target for an absolute reduction in GHG emissions yet
GHG emissions and Carbon intensity
Scope 1 + 2 GHG emissions (in tons of CO2e) divided by the company's Revenues (in USDm) for the same period
Regeneron Pharmaceuticals, Inc reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 92 Kt (+11/+14% y-o-y). At the sime time, carbon intensity tumbled to 5.7 t (-3.8 /-40% y-o-y).
Regeneron Pharmaceuticals, Inc's Scope 3 emissions grew to 822 Kt (
The company has not set a company-wide target for an absolute reduction in GHG emissions yet.